BDNF and depressive symptom measurement: Additionally, lurasidone has been demonstrated to exert antidepressant properties through a direct modulation of BDNF in prefrontal cortex of animal models of depressive states, thus suggesting a crucial impact of this drug on pathophysiologic neuroplastic mechanisms underlying depression [82,83].